UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Issues in modern bone histomorphometry

Bone (New York, N.Y.), 2011-11, Vol.49 (5), p.955-964

2011

Volltextzugriff (PDF)

Periosteum: biology, regulation, and response to osteoporosis therapies

Bone (New York, N.Y.), 2004-11, Vol.35 (5), p.1003-1012

2004

Volltextzugriff (PDF)

Stress fracture of bone under physiological multiaxial cyclic loading: Activity-based predictive models

Bone (New York, N.Y.), 2024-10, p.117279, Article 117279

2024

Volltextzugriff (PDF)

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis

Bone (New York, N.Y.), 2007-09, Vol.41 (3), p.378-385

2007

Volltextzugriff (PDF)

Effects of anti-resorptive treatment on the material properties of individual canine trabeculae in cyclic tensile tests

Bone (New York, N.Y.), 2021-09, Vol.150, p.115995-115995, Article 115995

2021

Volltextzugriff (PDF)

Six months of voluntary alcohol consumption in male cynomolgus macaques reduces intracortical bone porosity without altering mineralization or mechanical properties

Bone (New York, N.Y.), 2024-08, Vol.185, p.117111, Article 117111

2024

Volltextzugriff (PDF)

The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate

Bone (New York, N.Y.), 2014-07, Vol.64, p.57-64

2014

Volltextzugriff (PDF)

Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia

Bone (New York, N.Y.), 2006-11, Vol.39 (5), p.1053-1058

2006

Volltextzugriff (PDF)

Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs

Bone (New York, N.Y.), 2003-12, Vol.33 (6), p.960-969

2003

Volltextzugriff (PDF)

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys ( Macaca fascicularis)

Bone (New York, N.Y.), 2001-02, Vol.28 (2), p.150-159

2001

Volltextzugriff (PDF)

Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading

Bone (New York, N.Y.), 2007-04, Vol.40 (4), p.1172-1177

2007

Volltextzugriff (PDF)

Bisphosphonates do not alter the rate of secondary mineralization

Bone (New York, N.Y.), 2011-10, Vol.49 (4), p.701-705

2011

Volltextzugriff (PDF)

Identification of material parameters based on Mohr–Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone

Bone (New York, N.Y.), 2008-10, Vol.43 (4), p.775-780

2008

Volltextzugriff (PDF)

Response to Courtney et al

Bone (New York, N.Y.), 2016-08, Vol.89, p.77-79

2016

Volltextzugriff (PDF)

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

Bone (New York, N.Y.), 2001-05, Vol.28 (5), p.538-547

2001

Volltextzugriff (PDF)

Improvement of Cancellous Bone Microstructure in Patients on Teriparatide Following Alendronate Pretreatment

Bone (New York, N.Y.), 2016-08, Vol.89, p.16-24

2016

Volltextzugriff (PDF)

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading

Bone (New York, N.Y.), 2010-01, Vol.46 (1), p.203-207

2010

Volltextzugriff (PDF)

Corrigendum to “The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate”[Bone 64 (2014) 57–64]

Bone (New York, N.Y.), 2016-02, Vol.83, p.283-283

2016

Volltextzugriff (PDF)

Imaging bone microdamage in vivo with positron emission tomography

Bone (New York, N.Y.), 2005-12, Vol.37 (6), p.819-824

2005

Volltextzugriff (PDF)

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate

Bone (New York, N.Y.), 2011-07, Vol.49 (1), p.128-132

2011

Volltextzugriff (PDF)

Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment

Bone (New York, N.Y.), 2014-02, Vol.59, p.139-147

2014

Volltextzugriff (PDF)

Prior bisphosphonate use does not blunt the effect of teriparatide (PTH[1–34]) on bone mineral and matrix properties in bone forming trabecular surfaces

Bone (New York, N.Y.), 2011-05, Vol.48, p.S219-S219

2011

Volltextzugriff (PDF)

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate: Bisphosphonates

Bone (New York, N.Y.), 2011, Vol.49 (1), p.128-132

2011

Volltextzugriff (PDF)

Do different fluorochrome labels give equivalent histomorphometric information?

Bone (New York, N.Y.), 1992, Vol.13 (6), p.443-446

1992

Volltextzugriff (PDF)

Risedronate treatment does not increase microdamage in the canine femoral neck

Bone (New York, N.Y.), 1995-06, Vol.16 (6), p.643-650

1995

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBone

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(28)
Ingenta
(28)
Elsevier ScienceDirect Journals Complete
(28)
MEDLINE
(19)
IngentaConnect Journals
(13)

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Issues in modern bone histomorphometry

Periosteum: biology, regulation, and response to osteoporosis therapies

Stress fracture of bone under physiological multiaxial cyclic loading: Activity-based predictive models

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis

Effects of anti-resorptive treatment on the material properties of individual canine trabeculae in cyclic tensile tests

Six months of voluntary alcohol consumption in male cynomolgus macaques reduces intracortical bone porosity without altering mineralization or mechanical properties

The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate

Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia

Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys ( Macaca fascicularis)

Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading

Bisphosphonates do not alter the rate of secondary mineralization

Identification of material parameters based on Mohr–Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone

Response to Courtney et al

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

Improvement of Cancellous Bone Microstructure in Patients on Teriparatide Following Alendronate Pretreatment

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading

Corrigendum to “The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate”[Bone 64 (2014) 57–64]

Imaging bone microdamage in vivo with positron emission tomography

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate

Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment

Prior bisphosphonate use does not blunt the effect of teriparatide (PTH[1–34]) on bone mineral and matrix properties in bone forming trabecular surfaces

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate: Bisphosphonates

Do different fluorochrome labels give equivalent histomorphometric information?

Risedronate treatment does not increase microdamage in the canine femoral neck

Aktive Filter

Suchergebnisse filtern